TERT and glioblastoma: Recently, we found that sonobiopsy improved the detection sensitivity of glioblastoma (GBM) tumor-specific EGFRvIII mutation from 7.14 to 64.71% and TERT C228T from 14.29 to 45.83% in a mouse GBM model.